缺铁对慢性丙型肝炎病毒感染的影响。
The effect of iron depletion on chronic hepatitis C virus infection.
机构信息
Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Azienda Ospedaliera di Verona, Ospedale Policlinico, Piazzale Ludovico Scuro, Verona, 37134, Italy,
出版信息
Hepatol Int. 2008 Sep;2(3):335-40. doi: 10.1007/s12072-008-9076-z. Epub 2008 May 8.
Abstract
Increasing evidence exists that iron overload, a common finding in chronic hepatitis C virus (HCV) infection, plays an important role in the pathophysiology of this disease. The mechanisms by which iron excess induces liver damage along with the benefit of iron depletion via phlebotomy on biochemical and histological outcomes in patients with chronic HCV infection have been discussed in this review. Finally, we focus on the effect of iron reduction on the rate of response to interferon antiviral therapy.
摘要
越来越多的证据表明，铁过载是慢性丙型肝炎病毒（HCV）感染的常见发现，在该病的病理生理学中起着重要作用。本文综述了铁过载诱导肝损伤的机制，以及通过放血去除铁对慢性 HCV 感染患者的生化和组织学结果的益处。最后，我们重点讨论了铁减少对干扰素抗病毒治疗反应率的影响。
相似文献
1
The effect of iron depletion on chronic hepatitis C virus infection.缺铁对慢性丙型肝炎病毒感染的影响。
Hepatol Int. 2008 Sep;2(3):335-40. doi: 10.1007/s12072-008-9076-z. Epub 2008 May 8.
2
Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy.对于对干扰素治疗无反应的慢性丙型肝炎患者，铁耗竭在诱导病毒学应答方面无效。
Am J Gastroenterol. 1999 Dec;94(12):3571-5. doi: 10.1111/j.1572-0241.1999.01648.x.
3
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.慢性丙型肝炎患者铁减少与干扰素-α治疗的持续应答：一项意大利多中心随机研究的结果
Am J Gastroenterol. 2002 May;97(5):1204-10. doi: 10.1111/j.1572-0241.2002.05705.x.
4
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.一项关于铁缺乏对慢性丙型肝炎患者α干扰素长期反应影响的前瞻性随机对照试验。
J Hepatol. 1998 Mar;28(3):369-74. doi: 10.1016/s0168-8278(98)80308-5.
5
Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.非酒精性脂肪性肝病和慢性丙型肝炎病毒感染中的葡萄糖异常：铁过载的作用。
Diabetes Metab Res Rev. 2009 Jul;25(5):403-10. doi: 10.1002/dmrr.972.
6
7
Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.低铁调素可引发丙型肝炎患者的肝脏铁蓄积。
Nephrol Dial Transplant. 2014 Jun;29(6):1141-4. doi: 10.1093/ndt/gft467. Epub 2013 Nov 27.
8
[Significance of iron reduction for the therapy of chronic hepatitis C].[铁减少对慢性丙型肝炎治疗的意义]
Vojnosanit Pregl. 2005 Feb;62(2):161-4. doi: 10.2298/vsp0502161n.
9
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C.肝脏铁含量影响慢性丙型肝炎患者对干扰素α治疗的反应。
Eur J Gastroenterol Hepatol. 1997 May;9(5):497-503. doi: 10.1097/00042737-199705000-00016.
10
Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.放血疗法对丙型肝炎病毒相关肌肉骨骼表现的有益作用。
Clin Rheumatol. 1998;17(5):390-2. doi: 10.1007/BF01450898.
引用本文的文献
1
The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review.红细胞分布宽度在慢性肝病中的预后标志物作用：文献综述。
Int J Mol Sci. 2023 Feb 9;24(4):3487. doi: 10.3390/ijms24043487.
2
Iron-Induced Hepatocarcinogenesis-Preventive Effects of Nutrients.铁诱导的肝癌发生——营养素的预防作用
Front Oncol. 2022 Jun 27;12:940552. doi: 10.3389/fonc.2022.940552. eCollection 2022.
3
Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.2019 年冠状病毒病（COVID-19）更新：从代谢重编程到免疫代谢。
J Med Virol. 2022 Oct;94(10):4611-4627. doi: 10.1002/jmv.27929. Epub 2022 Jun 20.
4
Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis.遗传性血色病疑似患者的基因型、铁蛋白水平和转铁蛋白饱和度。
Genes (Basel). 2021 Jul 28;12(8):1162. doi: 10.3390/genes12081162.
5
Hyperferritinemia-A Clinical Overview.高铁蛋白血症——临床概述
J Clin Med. 2021 May 7;10(9):2008. doi: 10.3390/jcm10092008.
6
Iron at the Interface of Hepatocellular Carcinoma.铁在肝细胞癌中的作用。
Int J Mol Sci. 2021 Apr 15;22(8):4097. doi: 10.3390/ijms22084097.
7
Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.输血后丙型肝炎病毒感染与相关临床参数在β-地中海贫血个体中的表现。
Indian J Med Res. 2018 Jun;147(6):581-587. doi: 10.4103/ijmr.IJMR_127_16.
8
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?透析患者何时应避免、尽量减少或停止补充铁剂？
Semin Dial. 2019 Jan;32(1):22-29. doi: 10.1111/sdi.12732. Epub 2018 Jun 28.
9
Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C.在慢性丙型肝炎的有效治疗期间，血清铁调素水平恢复正常，但α-1-抗胰蛋白酶水平未恢复正常。
Clin Exp Hepatol. 2017 Dec;3(4):203-208. doi: 10.5114/ceh.2017.71573. Epub 2017 Nov 16.
10
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients.丙型肝炎病毒（HCV）患者铁减少治疗后血清甲胎蛋白水平改善
ISRN Hepatol. 2014 Feb 4;2014:875140. doi: 10.1155/2014/875140. eCollection 2014.
本文引用的文献
1
Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.长期放血疗法联合低铁饮食疗法可降低慢性丙型肝炎发展为肝细胞癌的风险。
J Gastroenterol. 2007 Oct;42(10):830-6. doi: 10.1007/s00535-007-2095-z. Epub 2007 Oct 15.
2
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.肝铁蓄积与慢性丙型肝炎的疾病进展及对干扰素/利巴韦林联合治疗的耐药性相关。
J Gastroenterol Hepatol. 2007 Nov;22(11):1886-93. doi: 10.1111/j.1440-1746.2006.04759.x.
3
Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.放血疗法可改善慢性丙型肝炎患者对干扰素的治疗反应：六项前瞻性随机对照试验的荟萃分析。
Dig Dis Sci. 2008 Mar;53(3):815-22. doi: 10.1007/s10620-007-9945-7. Epub 2007 Sep 12.
4
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.铁基因、代谢紊乱及丙型肝炎病毒（HCV）在HCV慢性肝炎铁调节异常发病机制中的相对作用
Haematologica. 2007 Aug;92(8):1037-42. doi: 10.3324/haematol.11281. Epub 2007 Jul 20.
5
Molecular mechanism of iron metabolism and overload in chronic hepatitis C.丙型肝炎中铁代谢及铁过载的分子机制
J Gastroenterol. 2007 Jan;42(1):96-9. doi: 10.1007/s00535-006-1983-y.
6
Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study.丙型肝炎病毒相关性肝硬化患者6个月铁减少治疗的疗效和安全性：一项初步研究。
J Gastroenterol. 2007 Jan;42(1):49-55. doi: 10.1007/s00535-006-1967-y. Epub 2007 Feb 16.
7
Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.铁缺乏对慢性丙型肝炎患者肝纤维化、氧化应激血清标志物及血清肝酶的影响：一项初步研究结果
Liver Int. 2007 Mar;27(2):268-73. doi: 10.1111/j.1478-3231.2007.01449.x.
8
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.铁和HFE突变在晚期慢性丙型肝炎再治疗期间对疾病严重程度及治疗反应的作用
Gastroenterology. 2006 Nov;131(5):1440-51. doi: 10.1053/j.gastro.2006.08.036. Epub 2006 Aug 18.
9
Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.通过放血进行铁减少疗法可降低慢性丙型肝炎患者的脂质过氧化和氧化应激。
J Gastroenterol. 2006 Sep;41(9):921-2. doi: 10.1007/s00535-006-1871-5.
10
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.慢性丙型肝炎中的铁蓄积：肝脏铁分布、HFE基因分型与疾病进程的关系
Am J Clin Pathol. 2005 Dec;124(6):846-53.
Zotero 插件